High-dose cholinergic therapy with rivastigmine patch does not prolong QTc time in patients with Alzheimer's disease.

Authors :: Riepe MW
Source :: The Journal of clinical psychiatry [J Clin Psychiatry] 2014 Mar; Vol. 75 (3), pp. 288.
Publication Year :: 2014

Subjects :: Cholinesterase Inhibitors administration & dosage
Dose-Response Relationship, Drug
Double-Blind Method
Heart physiopathology
Humans
Long QT Syndrome chemically induced
Phenylcarbamates administration & dosage
Rivastigmine
Transdermal Patch
Alzheimer Disease drug therapy
Cholinesterase Inhibitors adverse effects
Electrophysiological Phenomena drug effects
Heart drug effects
Phenylcarbamates adverse effects

Full Text Access

Tools